Skip to main content
Top
Published in: Calcified Tissue International 5/2013

01-05-2013 | Letter to the Editor

Re: “Is High Dose Vitamin D Harmful?”

Author: William B. Grant

Published in: Calcified Tissue International | Issue 5/2013

Login to get access

Excerpt

Sanders and colleagues [1] reviewed the evidence that high-dose or high serum 25-hydroxyvitamin D (25[OH]D) concentrations might be harmful [1]. It is reasonable that single, large doses of vitamin D might be harmful since they are not physiological doses. However, the evidence regarding possible harm associated with higher serum 25(OH)D concentrations within physiological limits comes from studies with systemic problems that are not generally recognized. The observational studies listed in Table 2 of Sanders et al. [1] were mostly prospective, with serum 25(OH)D concentrations measured at the time of enrollment and long follow-up periods, such as the two pancreatic cancer studies (refs. 79 and 80 in Sanders et al. [1]). A study of lymphoid cancer from the same cohort found an inverse correlation with 25(OH)D for follow-up less than 7 years but a direct correlation for longer follow-up [2]. The findings are also inconsistent with ecological studies with respect to solar UVB doses [3]. The study of esophageal and gastric cancers (ref. 76 in Sanders et al. [1]) was conducted in a region of China with very high rates of these cancers, and the results are inconsistent with ecological studies [3]. The prostate cancer study in Nordic countries (ref. 78 in Sanders et al. [1]) had up to a 17-year follow-up period, and a review of many other prospective studies of prostate cancer found no correlation with respect to serum 25(OH)D concentration at time of enrollment [4]. Ecological studies provide weak support for a role of solar UVB in reducing risk of prostate cancer, and some of the correlations found in the United States may be due to geographical variation or ethnic background [3]. Thus, the seasonal fluctuations of the serum 25(OH)D concentration hypothesis proposed by Vieth (ref. 26 in Sanders et al. [1]) may not be needed. …
Literature
1.
go back to reference Sanders KM, Nicholson GC, Ebeling PR (2013) Is high dose vitamin D harmful? Calcif Tissue Int 92(2):191–206PubMedCrossRef Sanders KM, Nicholson GC, Ebeling PR (2013) Is high dose vitamin D harmful? Calcif Tissue Int 92(2):191–206PubMedCrossRef
2.
go back to reference Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, Weinstein SJ, Morton LM, Schatzkin A, Virtamo J, Linet MS, Hartge P, Albanes D (2009) A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 124(4):979–986PubMedCrossRef Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, Weinstein SJ, Morton LM, Schatzkin A, Virtamo J, Linet MS, Hartge P, Albanes D (2009) A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 124(4):979–986PubMedCrossRef
3.
go back to reference Grant WB (2011) Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 3(3):199–204PubMed Grant WB (2011) Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 3(3):199–204PubMed
4.
go back to reference Grant WB (2012) Ecological studies of the UVB–vitamin D–cancer hypothesis: review. Anticancer Res 32(1):223–236PubMed Grant WB (2012) Ecological studies of the UVB–vitamin D–cancer hypothesis: review. Anticancer Res 32(1):223–236PubMed
5.
go back to reference Ensrud KE, Blackwell TL, Cauley JA, Cummings SR, Barrett-Connor E, Dam TT et al (2011) Circulating 25-hydroxyvitamin D levels and frailty in older men: the Osteoporotic Fractures in Men study. J Am Geriatr Soc 59(1):101–106PubMedCrossRef Ensrud KE, Blackwell TL, Cauley JA, Cummings SR, Barrett-Connor E, Dam TT et al (2011) Circulating 25-hydroxyvitamin D levels and frailty in older men: the Osteoporotic Fractures in Men study. J Am Geriatr Soc 59(1):101–106PubMedCrossRef
6.
go back to reference Lappe JM, Heaney RP (2012) Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol 4(2):95–100PubMedCrossRef Lappe JM, Heaney RP (2012) Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol 4(2):95–100PubMedCrossRef
Metadata
Title
Re: “Is High Dose Vitamin D Harmful?”
Author
William B. Grant
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 5/2013
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-013-9708-8

Other articles of this Issue 5/2013

Calcified Tissue International 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.